News
It has been found in a phase I study that patients taking Eli Lilly's investigational obesity drug eloralintide lost more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback